Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial

Overview of attention for article published in Trials, May 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 22,695 followers.

RT @ACasadevall1: Good to see that Germany is conducting RCT of convalescent plasma treating patients within 4 days of diagnosis using plas…

RT @ACasadevall1: Good to see that Germany is conducting RCT of convalescent plasma treating patients within 4 days of diagnosis using plas…

RT @ACasadevall1: Good to see that Germany is conducting RCT of convalescent plasma treating patients within 4 days of diagnosis using plas…

RT @ACasadevall1: Good to see that Germany is conducting RCT of convalescent plasma treating patients within 4 days of diagnosis using plas…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.